Commentary by Michael Poles MD, Associate Editor, Clinical Correlations
This week seems like a continuation of last week in a couple of ways. Last week our Editor-In-Chief, Dr. Neil Shapiro, wrote about the epidemic …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
Inpatient Diabetes Management: Case 5
October 25, 2007
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to Case 5 of our special diabetes series intended to highlight the essentials of diabetes …
FDA Approves Label Revision for Erectile Dysfunction Drugs
October 24, 2007
Commentary by Kathy Lee, Pharm.D. Pharmacy Practice Resident
On October 18 2007, the FDA announced the approval of labeling changes to erectile dysfunction (ED) drugs in the class known as phosphodiesterase type 5 (PDE-5) inhibitors. This …
ShortCuts-This Week in the Journals
October 22, 2007Commentary by Neil Shapiro MD, Editor-In-Chief, Clinical Correlations
As fall begins in earnest and the leaves start to change we find a diverse group of articles that make the cut and a few that didn’t quite make it but …
Clinical Pathology Conference 10/12/07-The Answer
October 19, 2007Case Presentation by Elizabeth Ross, MD, Chief Resident
Please review the posting of last week’s CPC here.
When you’re ready you can download the CPC Answer.
Class Act: Relieving the Obstruction – Surgical Approaches to the Management of Obstructive Sleep Apnea
October 18, 2007
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students …
Clinical Pharmacy Corner: How Do Sulfonylureas Work?
October 17, 2007Commentary by Helen Kourlas, PharmD and John Papadopoulas, PharmD, Pharmacology Section Editors
The sulfonylureas are members of a class of substituted arylsulfonylureas that have been used clinically since the 1950s. These agents are usually divided into two categories or generations. First generation agents include acetohexamide, chlorpropamide, tolazamide, and tolbutamide (the …
ShortCuts-This Week in the Journals
October 15, 2007
Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations
Moving through the journals this week, it is all about primary care.
There was an interesting article for Primary Care MDs in this week’s NEJM. …